By Elena Novak
Covers the European Green Deal, energy transition and the climate politics of the member states.
Colombian Inventor Turns Air Pollution into Biodegradable Raw Materials
Mariana Pérez's Ecol-Air system mimics human lungs to capture CO₂, NO₂, and SO₂. The technology converts these pollutants into biodegradable
UN Climate Chief Warns COP29 Finance Deal at Risk as EU Adjusts Position on China
UN climate chief Simon Stiell warned that political brinksmanship threatens to collapse negotiations for a new global climate finance goal a
COP29 Climate Finance Talks Stalled as Donor Disputes Threaten Baku Summit
The first week of the COP29 climate summit in Baku concluded with minimal progress on the critical issue of funding for developing nations.
EU States Divided on Microplastics Law as UN Treaty Negotiations Loom
European governments are divided over new rules to tackle microplastic pollution, with key states opposing controls on maritime transport. S
White Roofs Could Have Saved Hundreds in London Heatwave, Study Finds
Researchers from UCL and the University of Exeter found that white roofs could cool London by 0.8°C, potentially saving 249 lives during the
UK Map Reveals Over 2,700 Dangerous Wild Animals Kept as Pets Under 1976 Law
Born Free's interactive map reveals more than 2,700 dangerous wild animals, including venomous snakes and wild cats, are legally kept as pet
Beyond the EV: Why a Tech-First Approach to Transport Fails Europe's Climate Goals
Author Paris Marx argues that replacing combustion engines with electric vehicles is an insufficient response to the climate crisis. The pri
AI Breakthrough Uncovers First New Antibiotics in Decades to Combat MRSA
Researchers at MIT have identified the first new antibiotics in over 60 years using AI, targeting MRSA. The study, published in Nature, open
Antimicrobial Resistance: How Europe Is Fighting the Next Pandemic
Antimicrobial resistance could cause 10 million deaths annually by 2050. Europe is grappling with overuse in healthcare and agriculture. New
Biosimilars: EU's Cost-Saving Biologics Gain Ground in Healthcare Systems
Biosimilars are biological medicines that are cheaper copies of approved reference drugs, with the same efficacy and safety. The European Co
EU Revamps Health Innovation Rules to Reverse R&D Decline
The EU is losing ground in pharmaceutical innovation, with new drug development falling from 75 to 64 entities between 2011-2022. The Europe
How the EU Can Revitalize Its Pharmaceutical Innovation Pipeline
The EU is falling behind the US and Japan in pharmaceutical innovation. EMA Director General Emer Cooke calls for simpler regulatory pathway